| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Tomohito Gohda, Hiromichi Gotoh, Mitsuo Tanimoto, Michiko Sato, Hiroaki Io, Kayo Kaneko, Chieko Hamada, Yasuhiko Tomin. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertension research : official journal of the Japanese Society of Hypertension. vol 31. issue 1. 2008-04-15. PMID:18360022. |
insulin resistance and crp seemed to be closely correlated with fat-related parameters such as body mass index (bmi), vfa and sfa. |
2008-04-15 |
2023-08-12 |
Not clear |
| Tomohito Gohda, Hiromichi Gotoh, Mitsuo Tanimoto, Michiko Sato, Hiroaki Io, Kayo Kaneko, Chieko Hamada, Yasuhiko Tomin. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertension research : official journal of the Japanese Society of Hypertension. vol 31. issue 1. 2008-04-15. PMID:18360022. |
furthermore, crp was positively correlated with bmi, vfa, sfa, tg, high-density lipoprotein (hdl)-cholesterol, atherosclerosis index (ai), immunoreactive insulin (iri) and homa-ir in simple regression analysis. |
2008-04-15 |
2023-08-12 |
Not clear |
| Tomohito Gohda, Hiromichi Gotoh, Mitsuo Tanimoto, Michiko Sato, Hiroaki Io, Kayo Kaneko, Chieko Hamada, Yasuhiko Tomin. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertension research : official journal of the Japanese Society of Hypertension. vol 31. issue 1. 2008-04-15. PMID:18360022. |
in conclusion, insulin resistance and crp were related to fat-related parameters such as bmi, vfa and sfa in hd patients. |
2008-04-15 |
2023-08-12 |
Not clear |
| Tomohito Gohda, Hiromichi Gotoh, Mitsuo Tanimoto, Michiko Sato, Hiroaki Io, Kayo Kaneko, Chieko Hamada, Yasuhiko Tomin. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients. Hypertension research : official journal of the Japanese Society of Hypertension. vol 31. issue 1. 2008-04-15. PMID:18360022. |
furthermore, the contribution of sfa to insulin resistance was much higher than that of vfa, while the opposite relation was recognized for crp. |
2008-04-15 |
2023-08-12 |
Not clear |
| Marie-Hélène Gannagé-Yared, Cesar Yaghi, Bassem Habre, Simon Khalife, Roger Noun, Myrna Germanos-Haddad, Viviane Trak-Smayr. Osteoprotegerin in relation to body weight, lipid parameters insulin sensitivity, adipocytokines, and C-reactive protein in obese and non-obese young individuals: results from both cross-sectional and interventional study. European journal of endocrinology. vol 158. issue 3. 2008-04-09. PMID:18299469. |
we analyzed the relation of osteoprotegerin (opg) with insulin sensitivity, lipid profile, serum glutamic pyruvic transaminase (sgpt), adipocytokines, and c-reactive protein (crp) in obese and non-obese subjects. |
2008-04-09 |
2023-08-12 |
human |
| Matthew R Smith, Hang Lee, Mary Anne Fallon, David M Natha. Adipocytokines, obesity, and insulin resistance during combined androgen blockade for prostate cancer. Urology. vol 71. issue 2. 2008-04-08. PMID:18308111. |
to better characterize the metabolic effects of gonadotropin-releasing hormone agonist treatment, we prospectively evaluated the changes in body composition, insulin sensitivity, and levels of adiponectin, resistin, c-reactive protein (crp), and plasminogen activator inhibitor type 1 (pai-1). |
2008-04-08 |
2023-08-12 |
Not clear |
| Guan-jie Fan, Xian-yu Tang, Shuang-lei L. [Effects of Jiangtang Bushen Recipe on serum C-reactive protein, tumor necrosis factor-alpha and interleukin-6 in patients with type 2 diabetes mellitus]. Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine. vol 26. issue 4. 2008-04-07. PMID:16689001. |
fasting blood glucose (fbg), fasting insulin (fins), interleukin-6 (il-6), tumor necrosis factor-a (tnf-a) and c-reactive protein (crp) were measured, and insulin sensitive index (isi) and clinical tcm symptom score were calculated before and after treatment. |
2008-04-07 |
2023-08-12 |
Not clear |
| Marc R Blackman, Ranganath Muniyappa, Mildred Wilson, Barbara E Moquin, Howard L Baldwin, Kelli A Wong, Christopher Snyder, Michael Magalnick, Shaan Alli, James Reynolds, Seth M Steinberg, Raphaela Goldbach-Mansk. Diurnal secretion of growth hormone, cortisol, and dehydroepiandrosterone in pre- and perimenopausal women with active rheumatoid arthritis: a pilot case-control study. Arthritis research & therapy. vol 9. issue 4. 2008-04-03. PMID:17662149. |
sera obtained after overnight fasting were assayed for igf-i, igf-binding protein (igfbp)-1, igfbp-3, c-reactive protein (crp), interleukin-6 (il-6), glucose, insulin, and lipids. |
2008-04-03 |
2023-08-12 |
human |
| Aaron S Kelly, Andrea M Thelen, Daniel R Kaiser, J Michael Gonzalez-Campoy, Alan J Ban. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vascular medicine (London, England). vol 12. issue 4. 2008-03-20. PMID:18048467. |
the following variables were measured pre- and post-treatment: glucose, insulin, homeostasis model assessment (homa), hemoglobin a1c (hba1c), c-peptide, blood pressure, lipids, c-reactive protein (crp), adma, 8-isoprostane, oxidized ldl cholesterol, brachial artery flow-mediated dilation (fmd), endothelium-independent dilation (eid), and brachial and carotid artery stiffness. |
2008-03-20 |
2023-08-12 |
Not clear |
| Hamiyet Yilmaz, Alptekin Gursoy, Mustafa Sahin, Nilgun Guvener Demira. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes. Acta diabetologica. vol 44. issue 4. 2008-03-12. PMID:17726570. |
the aim of this study was to compare the efficacy of treatment with insulin alone, insulin plus acarbose, insulin plus metformin, or insulin plus rosiglitazone in type 2 diabetic subjects who were previously on insulin monotherapy, and to evaluate the effects of these treatments on cardiovascular risk factors including lipid profile, c-reactive protein (crp) and fibrinogen. |
2008-03-12 |
2023-08-12 |
human |
| Hamiyet Yilmaz, Alptekin Gursoy, Mustafa Sahin, Nilgun Guvener Demira. Comparison of insulin monotherapy and combination therapy with insulin and metformin or insulin and rosiglitazone or insulin and acarbose in type 2 diabetes. Acta diabetologica. vol 44. issue 4. 2008-03-12. PMID:17726570. |
crp and fibrinogen levels decreased in all groups, but the decrease in fibrinogen level was significantly greater in insulin plus rosiglitazone group. |
2008-03-12 |
2023-08-12 |
human |
| Yuan-Xiang Meng, Earl S Ford, Chaoyang Li, Alexander Quarshie, Ahmad M Al-Mahmoud, Wayne Giles, Gary H Gibbons, Gregory Strayhor. Association of C-reactive protein with surrogate measures of insulin resistance among nondiabetic US from National Health and Nutrition Examination Survey 1999-2002. Clinical chemistry. vol 53. issue 12. 2008-03-10. PMID:17951292. |
increased c-reactive protein (crp) concentration and insulin resistance (ir) are associated with increased rates of adverse cardiovascular events. |
2008-03-10 |
2023-08-12 |
Not clear |
| Hisashi Makino, Kentaro Doi, Aki Hiuge, Ayako Nagumo, Sadanori Okada, Yoshihiro Miyamoto, Masaaki Suzuki, Yasunao Yoshimas. Impaired flow-mediated vasodilatation and insulin resistance in type 2 diabetic patients with albuminuria. Diabetes research and clinical practice. vol 79. issue 1. 2008-03-07. PMID:17904244. |
we evaluated flow-mediated dilatation of brachial artery (%fmd, one endothelial function marker associated with endogenous no production), von willebrand factor (vwf, endothelial activation marker), high-sensitive crp (hscrp, a low-grade inflammation marker), asymmetric dimethyl arginine (adma, an endogenous inhibitor of no synthesis), and insulin sensitivity by steady-state plasma glucose method. |
2008-03-07 |
2023-08-12 |
Not clear |
| Jerry R Greenfield, Lesley V Campbel. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Current diabetes reviews. vol 2. issue 2. 2008-02-27. PMID:18220627. |
this conclusion is predominantly drawn from studies demonstrating associations between elevated (but 'normal range') levels of circulating acute phase inflammatory markers, typified by c-reactive protein (crp), and indices of insulin resistance and the development of type 2 diabetes. |
2008-02-27 |
2023-08-12 |
Not clear |
| Jerry R Greenfield, Lesley V Campbel. Relationship between inflammation, insulin resistance and type 2 diabetes: 'cause or effect'? Current diabetes reviews. vol 2. issue 2. 2008-02-27. PMID:18220627. |
in this review, we present evidence to support the suggestion that body fat is the primary determinant of circulating inflammatory marker levels in the basal state and that marginally elevated levels of circulating interleukin-6 and crp in obesity are a consequence rather than a cause of insulin resistance. |
2008-02-27 |
2023-08-12 |
Not clear |
| D A de Luis, M G Sagrado, R Aller, O Izaola, R Cond. Influence of ALA54THR polymorphism of fatty acid-binding protein 2 on obesity and cardiovascular risk factors. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 39. issue 11. 2008-02-14. PMID:17992640. |
an indirect calorimetry, tetrapolar electrical bioimpedance, blood pressure, a serial assessment of nutritional intake with 3 days of written food records, and biochemical analysis (lipid profile, adipocytokines, insulin, crp, and lipoprotein-a) were performed. |
2008-02-14 |
2023-08-12 |
Not clear |
| C Bulcão, F M A Giuffrida, F F Ribeiro-Filho, S R G Ferreir. Are the beneficial cardiovascular effects of simvastatin and metformin also associated with a hormone-dependent mechanism improving insulin sensitivity? Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. vol 40. issue 2. 2008-01-31. PMID:17273659. |
the objective of the present study was to evaluate the effect of simvastatin therapy on insulin resistance and on leptin, adiponectin, and c-reactive protein (crp) levels, as compared to metformin, in overweight pre-diabetic subjects. |
2008-01-31 |
2023-08-12 |
human |
| K Krzyzanowska, F Mittermayer, W Krugluger, M Roden, G Schernthaner, M Wolz. Adiponectin concentrations increase during acute FFA elevation in humans treated with rosiglitazone. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. vol 39. issue 10. 2008-01-16. PMID:17952842. |
blood for determination of adiponectin, c-reactive protein (crp), leptin, resistin, ffas, glucose, and insulin was drawn at baseline and on day 21 before and after 5 hours of triglyceride/heparin infusion. |
2008-01-16 |
2023-08-12 |
human |
| Mitsuhisa Komatsu, Hirokazu Ohfusa, Toru Aizawa, Kiyoshi Hashizum. Adiponectin inversely correlates with high sensitive C-reactive protein and triglycerides, but not with insulin sensitivity, in apparently healthy Japanese men. Endocrine journal. vol 54. issue 4. 2008-01-14. PMID:17575367. |
to explore physiological and pathophysiological significance of adiponectin in the japanese general population, we systematically analyzed the relationship between adiponectin and high sensitive crp (hscrp), lipids, insulin sensitivity, and anthropometric parameters in 166 consecutive adult male health examinees. |
2008-01-14 |
2023-08-12 |
human |
| C P Fischer, A Berntsen, L B Perstrup, P Eskildsen, B K Pederse. Plasma levels of interleukin-6 and C-reactive protein are associated with physical inactivity independent of obesity. Scandinavian journal of medicine & science in sports. vol 17. issue 5. 2008-01-08. PMID:17076827. |
obesity was associated with elevated insulin, c-peptide, triglycerides, low-density lipoprotein, il-6, crp, and adiponectin (all p<0.05). |
2008-01-08 |
2023-08-12 |
human |